MetaCap

Femasys (FEMY) vs SANUWAVE Health (SNWV)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Femasys (FEMY) has outperformed SANUWAVE Health (SNWV) over the past year, losing 93.3% versus a loss of 95.5%. SANUWAVE Health is the larger company by market cap ($12.9 million vs $10.7 million), about 1.2 times the size, while Femasys is growing revenue faster (+40.8% vs +35.0%). SANUWAVE Health converts more of its revenue into profit, with a net margin of 26.8% versus -812.3%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

FEMY-93.26%SNWV-95.48%
+15%-43%-101%
Nov 21, 20251 yearNov 20, 2026
FEMY-95.23%SNWV-88.48%
+263%+75%-112%
Oct 14, 20245 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

FEMY versus SNWV key metrics
MetricFEMYSNWV
Share price$1.24$1.50
Market cap$10.73M$12.90M
1-day change0.00%-5.66%
YTD return-89.24%-94.97%
1-year return-93.26%-95.48%
5-year return-98.63%—
EPS (TTM)$-1.79$-0.38
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$2.29M$44.05M
Revenue growth (YoY)+40.77%+34.98%
Net income (latest FY)$-18.63M$11.81M
Gross margin61.96%77.11%
Operating margin-766.95%11.23%
Net margin-812.27%26.82%
52-week high$20.80$35.29
52-week low$1.07$1.48
Distance from 52-week high-94.04%-95.75%
Analyst consensusnone—
Avg. price target upside+1055.65%—
Average volume110.75K78.45K
Shares outstanding8.66M8.60M
Employees5155
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • SANUWAVE Health is more profitable, keeping 26.8 cents of every revenue dollar as net income versus -812.3 cents for Femasys.
  • Femasys grew revenue faster in its latest fiscal year (+40.77% vs +34.98%).

About Femasys

FEMY stock →

Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation.

Health Care · Medical/Dental Instruments · 51 employees

About SANUWAVE Health

SNWV stock →

SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally.

Health Care · Medical/Dental Instruments · 55 employees

FEMY vs SNWV FAQ

Which is bigger, Femasys or SANUWAVE Health?

SANUWAVE Health (SNWV) is larger, with a market capitalization of $12.90M compared with $10.73M for Femasys (FEMY).

Which stock has performed better over the past year, FEMY or SNWV?

FEMY returned -93.26% over the past 12 months, compared with -95.48% for SNWV (price return, excluding dividends). Past performance does not predict future results.

Are Femasys and SANUWAVE Health in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons